{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:49:10Z","timestamp":1778611750046,"version":"3.51.4"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"2","content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017156","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T22:01:12Z","timestamp":1298066472000},"page":"e17156","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":102,"title":["O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation"],"prefix":"10.1371","volume":"6","author":[{"given":"Simone","family":"Kreth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Thon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Eigenbrod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Ledderose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Egensperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg C.","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans A.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig C.","family":"Hinske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich W.","family":"Kreth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","article-title":"Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.","volume":"64","author":"H Ohgaki","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.","volume":"10","author":"R Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma.","volume":"352","author":"ME Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1200\/JCO.2009.23.6497","article-title":"NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.","volume":"27","author":"W Wick","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.dnarep.2007.03.008","article-title":"MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.","volume":"6","author":"B Kaina","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/neuonc\/nop003","article-title":"O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients.","volume":"12","author":"S Spiegl-Kreinecker","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref8","article-title":"MGMT activity, promoter methylation and immunohistochemistry of pre-treatment and recurrent malignant gliomas: A comparative study on astrocytoma and glioblastoma.","author":"M Christmann","year":"2010","journal-title":"Int J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1750-3639.2008.00153.x","article-title":"Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.","volume":"18","author":"M Preusser","year":"2008","journal-title":"Brain Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1215\/15228517-2009-001","article-title":"Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas.","volume":"11","author":"S Everhard","year":"2009","journal-title":"Neuro Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1038\/sj.onc.1205581","article-title":"The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.","volume":"21","author":"M Sato","year":"2002","journal-title":"Oncogene"},{"key":"ref12","first-page":"4415","article-title":"Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.","volume":"9","author":"I Girault","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ijc.21807","article-title":"Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues.","volume":"119","author":"E Arai","year":"2006","journal-title":"Int J Cancer"},{"key":"ref14","article-title":"The Clinical Evaluation of Chemotherapeutic Agents in Cancer.","author":"DA Karnofsky","year":"1949"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma.","volume":"8","author":"DR Macdonald","year":"1990","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.","volume":"26","author":"AA Brandes","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system.","volume":"114","author":"DN Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.","volume":"7","author":"W Stummer","year":"2006","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/NEN.0b013e3181bee1f1","article-title":"Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p\/19q and TP53 mutations in World Health Organization grade II gliomas.","volume":"68","author":"N Thon","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/ijc.23020","article-title":"Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas.","volume":"121","author":"EM Grasbon-Frodl","year":"2007","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ijc.20575","article-title":"Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.","volume":"113","author":"M Mollemann","year":"2005","journal-title":"Int J Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.","volume":"343","author":"M Esteller","year":"2000","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/neuonc\/nop072","article-title":"Identification of valid endogenous control genes for determining gene expression in human glioma.","volume":"12","author":"S Kreth","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref24","article-title":"Predominant influence of MGMT methylation in non-resectable GBM after radiotherapy plus temozolomide.","author":"N Thon","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non parametric estimation for incomplete observation.","volume":"53","author":"E Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1158\/0008-5472.CAN-06-3820","article-title":"Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase.","volume":"67","author":"I Lavon","year":"2007","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc1571","article-title":"Detection and interpretation of altered methylation patterns in cancer cells.","volume":"5","author":"T Ushijima","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/nar\/27.11.2291","article-title":"The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.","volume":"27","author":"KD Robertson","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/cncr.22087","article-title":"Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.","volume":"107","author":"H Kim","year":"2006","journal-title":"Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI40706","article-title":"The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.","volume":"120","author":"RK Lin","year":"2010","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1750-3639.2008.00185.x","article-title":"RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.","volume":"19","author":"A Lorente","year":"2009","journal-title":"Brain Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.","volume":"55","author":"SA Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/PAS.0b013e318164c3f0","article-title":"Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.","volume":"32","author":"K Sasai","year":"2008","journal-title":"Am J Surg Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T09:07:30Z","timestamp":1712221650000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017156"}},"subtitle":[],"editor":[{"given":"Benjamin","family":"Rich","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017156","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]}}}